Short answer · Medically reviewed summary · Last updated: 2026-05-08
Myelodysplastic Syndromes (MDS) are primarily classified under the ICD-10 code D46, which covers various subtypes of these hematopoietic disorders. Under the older ICD-9 system, these conditions were typically categorized under code 238.72 (Neoplasm of uncertain behavior of bone marrow). What are Myelodysplastic Syndromes? Myelodysplastic Syndromes are a group of diverse bone marrow disorders in which the bone marrow does not produce enough healthy blood cells.
ICD10 code of Myelodysplastic Syndromes and ICD9 code
ICD-10 and ICD-9 codes for Myelodysplastic Syndromes, with classification details for clinicians, coders and patients.
Myelodysplastic Syndromes (MDS) are primarily classified under the ICD-10 code D46, which covers various subtypes of these hematopoietic disorders. Under the older ICD-9 system, these conditions were typically categorized under code 238.72 (Neoplasm of uncertain behavior of bone marrow).
What are Myelodysplastic Syndromes?
Myelodysplastic Syndromes are a group of diverse bone marrow disorders in which the bone marrow does not produce enough healthy blood cells. Because Myelodysplastic Syndromes involve ineffective blood cell production, patients often experience anemia, neutropenia, or thrombocytopenia. At DiseaseMaps.org, we currently support a community of 36 individuals navigating the complexities of Myelodysplastic Syndromes, providing a space for shared experiences and peer support.
How are Myelodysplastic Syndromes classified?
The classification of Myelodysplastic Syndromes is essential for determining prognosis and treatment pathways. Clinicians use the World Health Organization (WHO) classification system, which categorizes Myelodysplastic Syndromes based on the morphology of blood cells and genetic findings. Key diagnostic criteria include:
- Persistent cytopenia (low blood cell counts) in one or more cell lineages.
- Morphological dysplasia (abnormal cell appearance) in the bone marrow.
- Presence of specific cytogenetic abnormalities, such as del(5q).
- Blast percentage in the blood and bone marrow.
What is the clinical significance of these codes?
Accurate coding for Myelodysplastic Syndromes is vital for clinical documentation, insurance authorization for treatments like hypomethylating agents, and identifying eligibility for clinical trials. While ICD-10 code D46 is the standard, specific decimal extensions (e.g., D46.0, D46.1) are used to denote the specific subtype of Myelodysplastic Syndromes identified during pathology review.
Next steps
- Consult with a hematologist-oncologist specializing in bone marrow failure syndromes.
- Request a copy of your bone marrow biopsy and cytogenetic report for your personal health records.
- Join the Myelodysplastic Syndromes community at DiseaseMaps.org to connect with others who understand your journey.
- Discuss current clinical trials and emerging therapies with your care team.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.
References
- World Health Organization (WHO) Classification of Tumours of Haematopoietic and Lymphoid Tissues.
- NIH Genetic and Rare Diseases Information Center (GARD): Myelodysplastic Syndromes.
- Orphanet: Rare Disease Database (ORPHA:589).
- MDS Foundation: Understanding Myelodysplastic Syndromes.
